Unknown

Dataset Information

0

MicroRNA biomarker identification for pediatric acute myeloid leukemia based on a novel bioinformatics model.


ABSTRACT: Acute myeloid leukemia (AML) in children is a complex and heterogeneous disease. The identification of reliable and stable molecular biomarkers for diagnosis, especially early diagnosis, remains a significant therapeutic challenge. Aberrant microRNA expression could be used for cancer diagnosis and treatment selection. Here, we describe a novel bioinformatics model for the prediction of microRNA biomarkers for the diagnosis of paediatric AML based on computational functional analysis of the microRNA regulatory network substructure. microRNA-196b, microRNA-155 and microRNA-25 were identified as putative diagnostic biomarkers for pediatric AML. Further systematic analysis confirmed the association of the predicted microRNAs with the leukemogenesis of AML. In vitro q-PCR experiments showed that microRNA-155 is significantly overexpressed in children with AML and microRNA-196b is significantly overexpressed in subgroups M4-M5 of the French-American-British classification system. These results suggest that microRNA-155 is a potential diagnostic biomarker for all subgroups of paediatric AML, whereas microRNA-196b is specific for subgroups M4-M5.

SUBMITTER: Yan W 

PROVIDER: S-EPMC4694912 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5721230 | biostudies-literature
| S-EPMC5217027 | biostudies-literature
| S-EPMC6186152 | biostudies-other
| S-EPMC6676650 | biostudies-literature
| S-EPMC8585857 | biostudies-literature
| S-EPMC3383013 | biostudies-literature
| S-EPMC10548603 | biostudies-literature
| S-EPMC10861362 | biostudies-literature
| S-EPMC5687675 | biostudies-literature
| S-EPMC7655922 | biostudies-literature